Preferred Label : Cancer Peptide Vaccine S-588410;
NCIt definition : A cancer peptide vaccine containing five human leukocyte antigen (HLA)-A*2402-restricted
epitope peptides derived from as of yet not disclosed oncoantigens, with potential
immunostimulating and antineoplastic activities. Upon administration of the cancer
peptide vaccine S-588410, the peptides may stimulate a cytotoxic T-lymphocyte (CTL)
response against cancer cells expressing the antigens. This decreases proliferation
of susceptible tumor cells.;
Molecule name : S-588410;
Origin ID : C121776;
UMLS CUI : C4053593;
Semantic type(s)
- concept_is_in_subset
